Regencell Bioscience Holdings Ltd
Stock Chart, Company Information, and Scan Results
$52.35(as of Jan 7, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regencell Bioscience Holdings Ltd Company Information, Fundamentals, and Technical Indicators
Stock Price$52.35
Ticker SymbolRGC
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees10
CountyUSA
Market Cap$13,371.0M
EBIDTA-3.7M
P/E Ratio-3,619.79
Forward P/E Ratio0.00
Earnings per Share-0.01
Profit Margin-Infinity%
RSI76.42
Shares Outstanding494.5M
ATR3.28
52-Week High83.60
Volume1,385,438
52-Week Low0.09
Book Value4.9M
P/B Ratio3,360.50
Upper Keltner28.09
P/S RatioInfinity
Lower Keltner13.31
Debt-to-Equity Ratio28.09
Next Earnings Date06/02/2026
Cash Surplus1.8M
Next Ex-Dividend DateUnknown
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Regencell Bioscience Holdings Ltd In Our Stock Scanner
As of Jan 07, 2026
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.